Fogorvosi szemle, 2013 (106. évfolyam, 1-4. szám)
2013-06-01 / 2. szám
58 FOGORVOSI SZEMLE 106. évf.2. sz. 2013. 4. Plouet J, Schilling J, Gospodarowicz D: Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J1989; 8: 3801-3806. 5. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, és mtsai: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 246: 1309-1312. 6. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N.: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-1309. 7. Pickkers P, Sprong T, Eijk L, Hoeven H, Smits P, Deuren M: Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability. Shock 2005; 24: 508-512. 8. Abman SH.: Recent advances in the pathogenesis and treatment of persistent pulmonary hypertension of the newborn. Neonatology 2007;91:283-290. 9. Aramoto H, Breslin JW. Pappas P J, Hobson RW, 2nd, Duran WN: Vascular endothelial growth factor stimulates differential signaling pathways in in vivo microcirculation. Am J Physiol Heart Circ Physiol 2004; 287: H1590-1598. 10. Cetinkaya BO, Acikgoz G, Ay as B, Aliyev E, Sakallioglu EE: Increased expression of vascular endothelial growth factor in cyclosporin A-induced gingival overgrowth in rats. J Perlodontol 2006; 77: 54-60. 11. Cetinkaya BO, Keles GC., Ayas B, Sakallioglu EE, Acikgoz G: The expression of vascular endothelial growth factor in a rat model at destruction and healing stages of periodontal disease. J Periodontol 2007; 78: 1129-1135. 12. Dvorak AM., Feng D: The vesiculo-vacuolar organelle (WO). A new endothelial cell permeability organelle. J Histochem Cytochem 2001; 49: 419-432. 13. Eriksson A, Cao R, Roy J, Tritsaris K, Wahlestedt C, Dissing S, és mtsai: Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability. Circulation 2003; 107:1532-1538. 14. Fernandez M, Mejias M, Angermayr B, Garcia-Pagan JC, Rodes J, Bosch J: Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. J Hepatol 2005; 43: 98-103. 15. Ferrara N, Gerber HP, Lecouter J: The biology of VEGF and its receptors. Nat Med 2003; 9: 669-676. 16. Johnson RB, Serio FG, Dai X: Vascular endothelial growth factors and progression of periodontal diseases. J Periodontol 1999; 70: 848-852. 17. Roberts WG, Palade GE: Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sei 1995; 108 ( Pt 6): 2369-2379. 18. Sakallioglu EE, Aliyev E, Lutfioglu M, Yavuz U, Acikgoz G: Vascular endothelial growth factor (VEGF) levels of gingiva and gingival crevicular fluid in diabetic and systemically healthy periodontitis patients. Clin Oral Investig 2007; 11: 115-120. 19. Weis SM, Cheresh DA: Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005; 437: 497-504. 20. Zachary I: Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor. Am J Physiol Cell Physiol 2001 ; 280: C1375-1386. 21. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L: VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 2006; 7: 359-371. 22. Boussat S, Eddahibi S, Coste A, Fataccioli V, Gouge M, Housset B, és mtsai: Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 2000; 279: L371-378. 23. Slevin M, Krupinski J, Slowik A, Kumar P, Szczudlik A, Gaffney J: Serial measurement of vascular endothelial growth factor and transforming growth factor-betal in serum of patients with acute ischemic stroke. Stroke 2000; 31: 1863-1870. 24. Ben Arush MW, Ben Barak A, Maurice S, Livne E: Serum VEGF as a significant marker of treatment response in hodgkin lymphoma. Pediatr Hematol Oncol 2007; 24: 111-115. 25. Shang ZJ, Li J. R, Li ZB: Upregulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma. J Oral Maxillofac Surg 2007; 65: 17-21. 26. Slomiany MG, Black LA., Kibbey MM, Day TA, Rosenzweig SA.: IGF-1 induced vascular endothelial growth factor secretion in head and neck squamous cell carcinoma. Biochem Biophys Res Commun 2006; 342: 851-858. 27. Yeo KT, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, és mtsai: Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res 1993; 53: 2912-2918. 28. Drevs J, Siegert P, Medinger M, Mross K, Strecker R, Zirrgiebel U, és mtsai: Phase I clinical study of AZD2171, an oral vascular endothelial growth factor signaling inhibitor, in patients with advanced solid tumors. J Clin Oncol 2007; 25: 3045-3054. 29. Ho QT, Kuo CJ: Vascular endothelial growth factor: biology and therapeutic applications. Int J Biochem Cell Biol2007; 39:1349-1357. 30. Manley PW, Bold G, Bruggen J, Fendrich G, Furet P, Mestan J, és mtsai: Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis. Biochim Biophys Acta 2004; 1697: 17-27. 31. Manning EA, Ullman JG, Leatherman JM, Asquith JM, Hansen TR, Armstrong TD. és mtsai: A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immunebased mechanism. Clin Cancer Res 2007; 13: 3951-3959. 32. Roberts N, Kloos B, Cassella M, Podgrabinska S, Persaud K, Wu Y. és mtsai: Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res 2006; 66: 2650-2657. 33. ZM323881 material sheet. Available at: http://www.tocris.com/ dispprod.php?ltemld=156230. Accessed: 21.01., 2013. 34. Bonakdar MP, Barber PM, Newman HN: The vasculature in chronic adult periodontitis: a qualitative and quantitative study. J Periodonfo/1997; 68: 50-58. 35. Degidi M, Artese L, Scarano A, Perrotti V, Gehrke P, Piattelli A: Inflammatory infiltrate, microvessel density, nitric oxide synthase expression, vascular endothelial growth factor expression, and proliferative activity in peri-implant soft tissues around titanium and zirconium oxide healing caps. J Periodontol 2006; 77: 73-80. 36. Orsini G, Murmura G, Artese L, Piattelli A, Piccirilli M, Caputi S: Tissue healing under provisional restorations with ovate pontics: a pilot human histological study. J Prosthet Dent 2006; 96: 252-257. 37. Prapulla DV, Sujatha PB., Pradeep AR: Gingival crevicular fluid VEGF levels in periodontal health and disease. J Periodontol 2007; 78: 1783-1787. 38. Mian R, Marshall JM: Effect of acute systemic hypoxia on vascular permeability and leucocyte adherence in the anaesthetised rat. Cardiovasc Res 1993; 27: 1531-1537. 39. Venturi GM., Tu L, Kadono T, Khan Al, Fujimoto Y, Oshel P. és mtsai: Leukocyte migration is regulated by L-selectin endoproteolytic release. Immunity 2003; 19: 713-724. 40. Diaz-Flores L, Gutierrez R. Varela H: Behavior of postcapillary venule pericytes during postnatal angiogenesis. J Morphol 1992; 213:33-45. 41. Hortobágyi L, Kis B, Hrabak A, Horvath B, Huszty G, Schweer H. és mtsai: Adaptation of the hypothalamic blood flow to chronic nitric oxide deficiency is independent of vasodilator prostanoids. Brain Res 2007; 1131: 129-137. 42. Ablonczy Z, Crosson CE: VEGF modulation of retinal pigment epithelium resistance. Exp Eye Res 2007. 43. Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, és mtsai: Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 1999; 5: 1369-1379. 44. Svensen CH: Vascular endothelial growth factor (VEGF) in plasma increases after hip surgery. J Clin Anesth 2004; 16: 435—439.
